The Advanced Therapies Apprenticeship Community welcomes its 300th apprentice

The Advanced Therapies Apprenticeship Community (ATAC), a programme established by the Cell and Gene Therapy Catapult in 2018, has announced the enrolment of its 300th apprentice.

ATAC was the first apprenticeship programme designed specifically to train and upskill individuals in developing, manufacturing and delivering advanced therapies. The purpose of the community is to create a supply of skilled talent ranging from manufacturing operatives to technical experts and researchers, to fuel the growth of the advanced therapies industry in the UK.

The first ATAC cohort comprised of 17 apprentices working for eight companies. It has now grown to see 300 apprentices enroll on its programmes, with 56 companies offering apprenticeships. Of the 300 apprentices who have enrolled, so far a total of 50 apprentices have completed their programme.

The apprenticeships are available in England, Scotland and Wales and are open to a wide range of people, from recent school leavers taking their first steps into the professional world, to senior managers and directors seeking to enhance their skills.

Find out more about the ATAC programme here: